These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 19317892)

  • 21. Sense and nonsense from a systems biology approach to microbial recombinant protein production.
    Sevastsyanovich YR; Alfasi SN; Cole JA
    Biotechnol Appl Biochem; 2010 Jan; 55(1):9-28. PubMed ID: 20044926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Small-scale expression of proteins in E. coli.
    Zerbs S; Giuliani S; Collart F
    Methods Enzymol; 2014; 536():117-31. PubMed ID: 24423272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microbial production of limonene and its derivatives: Achievements and perspectives.
    Ren Y; Liu S; Jin G; Yang X; Zhou YJ
    Biotechnol Adv; 2020 Nov; 44():107628. PubMed ID: 32882371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Production of recombinant therapeutic proteins in human cells: current achievements and future perspectives.
    Picanco-Castro V; Biaggio RT; Cova DT; Swiech K
    Protein Pept Lett; 2013 Dec; 20(12):1373-81. PubMed ID: 24261981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharming and transgenic plants.
    Liénard D; Sourrouille C; Gomord V; Faye L
    Biotechnol Annu Rev; 2007; 13():115-47. PubMed ID: 17875476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production of recombinant proteins and metabolites in yeasts: when are these systems better than bacterial production systems?
    Porro D; Gasser B; Fossati T; Maurer M; Branduardi P; Sauer M; Mattanovich D
    Appl Microbiol Biotechnol; 2011 Feb; 89(4):939-48. PubMed ID: 21125266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparing patient access to pharmaceuticals in the UK and US.
    Cohen J; Cairns C; Paquette C; Faden L
    Appl Health Econ Health Policy; 2006; 5(3):177-87. PubMed ID: 17132032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opportunities and challenges for the sustainable production of structurally complex diterpenoids in recombinant microbial systems.
    Kemper K; Hirte M; Reinbold M; Fuchs M; Brück T
    Beilstein J Org Chem; 2017; 13():845-854. PubMed ID: 28546842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Biosimilar Landscape: An Overview of Regulatory Approvals by the EMA and FDA.
    Gherghescu I; Delgado-Charro MB
    Pharmaceutics; 2020 Dec; 13(1):. PubMed ID: 33396369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyaluronidase (Vitrase)--ISTA: hyaluronidase--ISTA pharmaceuticals.
    Drugs R D; 2003; 4(3):194-7. PubMed ID: 12757408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabis-based medicines--GW pharmaceuticals: high CBD, high THC, medicinal cannabis--GW pharmaceuticals, THC:CBD.
    Drugs R D; 2003; 4(5):306-9. PubMed ID: 12952500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From Neanderthal to nanobiotech: from plant potions to pharming with plant factories.
    Sourrouille C; Marshall B; Liénard D; Faye L
    Methods Mol Biol; 2009; 483():1-23. PubMed ID: 19183890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Applications of CRISPR in a Microbial Cell Factory: From Genome Reconstruction to Metabolic Network Reprogramming.
    Wu Y; Liu Y; Lv X; Li J; Du G; Liu L
    ACS Synth Biol; 2020 Sep; 9(9):2228-2238. PubMed ID: 32794766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Manufacturing of recombinant therapeutic proteins in microbial systems.
    Graumann K; Premstaller A
    Biotechnol J; 2006 Feb; 1(2):164-86. PubMed ID: 16892246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant lectins: an array of tailor-made glycan-interaction biosynthetic tools.
    Oliveira C; Teixeira JA; Domingues L
    Crit Rev Biotechnol; 2013 Mar; 33(1):66-80. PubMed ID: 22530774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop.
    Kirkland D; Pfuhler S; Tweats D; Aardema M; Corvi R; Darroudi F; Elhajouji A; Glatt H; Hastwell P; Hayashi M; Kasper P; Kirchner S; Lynch A; Marzin D; Maurici D; Meunier JR; Müller L; Nohynek G; Parry J; Parry E; Thybaud V; Tice R; van Benthem J; Vanparys P; White P
    Mutat Res; 2007 Mar; 628(1):31-55. PubMed ID: 17293159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expanding the recombinant protein quality in Lactococcus lactis.
    Cano-Garrido O; Rueda FL; Sànchez-García L; Ruiz-Ávila L; Bosser R; Villaverde A; García-Fruitós E
    Microb Cell Fact; 2014 Dec; 13():167. PubMed ID: 25471301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mecasermin rinfabate: insulin-like growth factor-I/insulin-like growth factor binding protein-3, mecaserimin rinfibate, rhIGF-I/rhIGFBP-3.
    Drugs R D; 2005; 6(2):120-7. PubMed ID: 15777106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From flavors and pharmaceuticals to advanced biofuels: production of isoprenoids in Saccharomyces cerevisiae.
    Tippmann S; Chen Y; Siewers V; Nielsen J
    Biotechnol J; 2013 Dec; 8(12):1435-44. PubMed ID: 24227704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lactobacilli and pediococci as versatile cell factories - Evaluation of strain properties and genetic tools.
    Bosma EF; Forster J; Nielsen AT
    Biotechnol Adv; 2017 Jul; 35(4):419-442. PubMed ID: 28396124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.